QSS
IMUX icon

Quantitative Systematic Strategies’s Immunic IMUX Stock Holding History

Quantitative Systematic Strategies’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-51
Closed -$139K – 703
2018
Q2 		$139K Buy
+51
New +$118K 0.03% 581

Other funds holding IMUX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Quantitative Systematic Strategies's IMUX Position: Q3 2018 in Review

Quantitative Systematic Strategies sold out of Immunic (IMUX) in Q3 2018, closing a stake of 51 shares — an estimated $139K sold.

Quantitative Systematic Strategies first reported a position in IMUX in Q2 2018 and held it in 1 quarter. The position peaked at $139K in Q2 2018. 54 funds tracked by Wall St. Rank hold IMUX as of Q3 2018.

  • Quantitative Systematic Strategies reported no remaining Immunic position as of Q3 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 51 Immunic shares in Q3 2018, an estimated $139K.
  • Quantitative Systematic Strategies first reported a position in Immunic in Q2 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Immunic position peaked at $139K in Q2 2018.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q3 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.